SACRAMENTO, CA, May 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Boon Industries, Inc. (OTC PINK: BNOW) ("Boon" or the "Company"), an innovative bioscience company delivering solutions that benefit people and the planet, is pleased to announce that it has filed its Annual Report on Form 10-K with the Securities and Exchange Commission (SEC) for the year ended December 31, 2021. This is the first periodic report filed by the Company with the SEC since becoming subject to the reporting requirements of the Securities Exchange Act of 1934. The Company previously filed a Registration Statement with the SEC that became effective on February 14, 2022.
The full report is available at: https://www.sec.gov/ix?doc=/Archives/edgar/data/1877788/000187778822000013/bnow-10k.htm
Highlights of the filing include:
- A twenty-five percent increase in revenue in 2021 as compared to 2020.
- A reduction in stockholders' deficit from $197,700,000 to $69,387,000 as a result of retiring of Series A Preferred Stock.
- Net loss in 2021 increased by 20%.
During 2021, the Company generated $607,000 from financing activities from the issuance of convertible debt and used the proceeds primarily to market the Company's flagship product line, build a production facility, and pay professional fees in connection with becoming a fully reporting company.
"We are pleased to have filed our first 10-K with the SEC," stated Justin Gonzalez, CEO, Boon Industries. "Taking this step in reporting and transparency has been an important goal of management. While 2021 was a challenging year in which shareholders experienced dilution due to our necessary fundraising efforts, we look forward to growing the Company's revenue in 2022 which would reduce our need to engage in dilutive financings."
"I believe we have made great progress in establishing a sturdy foundation, from financial and organizational, to product development, to sales and marketing. We are clear that there remains much to do to further strengthen our foundation. To that end, we were able to retire stock last year and will continue to evaluate what is best for our shareholders and our brands in unison," added Gonzalez.
The company is working on updates to marketing deliverables, including communication to our valued investors and anticipates announcing these efforts early in Q2. Additionally, the Company is working to secure additional clients and the launching of market driven scientific research designed to support the specific value propositions that Boon products provide.
Gonzalez explained the importance of completing Boon's expanded co-manufacturing facility as integral to future revenue growth. "With our expanded footprint we are pursuing larger distribution opportunities for our core brands and have the production capacity to create new product offerings. We now have the ability and capacity to build additional revenue streams for the business and we are finally in the market ready position that we have worked so diligently to place ourselves," said Gonzalez.
About Boon Industries
Boon Industries, Inc. (OTC: BNOW) is an innovative bioscience company delivering solutions that benefit people and the planet. At the core of Boon's product offering is DiOx+™ and BioDox™, a chlorine dioxide disinfectant sterilizer. Chlorine dioxide has been approved by OSHA, FDA, EPA, and DOT. DiOx+ kills harmful pathogens without dangerous toxic exposure to the user or the environment. The proprietary chemical formulas and processes behind Boon's products make it ideal for sterilization of mission critical, high value medical equipment and disinfecting air and surfaces in laboratory and hospital environments. BioDox™ helps prevent agricultural crops from disease. Diox+™ is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers and ecommerce support facilities. The introduction of DiOx+ to the U.S. market follows 12 years of chlorine dioxide usage in global markets driven by Boon's CEO Justin Gonzalez. DiOx+ delivers on Boon's promise to provide the most effective, affordable solutions without sacrificing health and safety. DiOx+ is produced at Boon's manufacturing facility and corporate headquarters in Grass Valley, California
Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as "believes," "anticipates", "expects", "estimates", "may", "could", "would", "will", or "plan". Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management's expectations. Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law
Please note that from time to time the Company may post new information at its website boonindustries.com, or via its current social media accounts below:
LinkedIn:
Twitter:
The Company's most current Investor Presentation is available at the following link:
Company Contact
Boon Industries, Inc.
admin@boonindustries.com
Investor Relations & Financial Media
Integrity Media Inc.
team@integritymedia.com
Toll Free: (888) 216-3595
SACRAMENTO, CA, May 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Boon Industries, Inc. (OTC PINK: BNOW) ("Boon" or the "Company"), an innovative bioscience company delivering solutions that benefit people and the planet, is pleased to announce that it has filed its Annual Report on Form 10-K with the Securities and Exchange Commission (SEC) for the year ended December 31, 2021. This is the first periodic report filed by the Company with the SEC since becoming subject to the reporting requirements of the Securities Exchange Act of 1934. The Company previously filed a Registration Statement with the SEC that became effective on February 14, 2022.
加利福尼亚州萨克拉门托，2022年5月3日(Global Newswire)--通过NewMediaWire-Boon Industries，Inc.(场外交易PINK：BNOW)博恩公司是一家创新的生物科学公司，提供造福人类和地球的解决方案，该公司高兴地宣布，它已向美国证券交易委员会(美国证券交易委员会)提交了截至2021年12月31日的10-K表格年度报告。这是本公司自受1934年证券交易法的报告要求以来向美国证券交易委员会提交的第一份定期报告。该公司此前向美国证券交易委员会提交了一份注册声明，于2022年2月14日生效。
The full report is available at: https://www.sec.gov/ix?doc=/Archives/edgar/data/1877788/000187778822000013/bnow-10k.htm
报告全文可在以下网址查阅：https://www.sec.gov/ix?doc=/Archives/edgar/data/1877788/000187778822000013/bnow-10k.htm
Highlights of the filing include:
- A twenty-five percent increase in revenue in 2021 as compared to 2020.
- A reduction in stockholders' deficit from $197,700,000 to $69,387,000 as a result of retiring of Series A Preferred Stock.
- Net loss in 2021 increased by 20%.
- 与2020年相比，2021年的收入增长了25%。
- 由于A系列优先股的退出，股东的赤字从197,700,000美元减少到69,387,000美元。
- 2021年净亏损增加20%。
During 2021, the Company generated $607,000 from financing activities from the issuance of convertible debt and used the proceeds primarily to market the Company's flagship product line, build a production facility, and pay professional fees in connection with becoming a fully reporting company.
2021年期间，公司从发行可转换债券的融资活动中获得607,000美元，并将所得资金主要用于营销公司的旗舰产品线，建造生产设施，以及支付与成为一家全面报告公司相关的专业费用。
"We are pleased to have filed our first 10-K with the SEC," stated Justin Gonzalez, CEO, Boon Industries. "Taking this step in reporting and transparency has been an important goal of management. While 2021 was a challenging year in which shareholders experienced dilution due to our necessary fundraising efforts, we look forward to growing the Company's revenue in 2022 which would reduce our need to engage in dilutive financings."
博恩工业的首席执行官贾斯汀·冈萨雷斯说：“我们很高兴向美国证券交易委员会提交了我们的第一份10-K协议。”在报告和透明度方面迈出这一步一直是管理层的一个重要目标。虽然2021年是具有挑战性的一年，由于我们必要的筹资努力，股东们经历了稀释，但我们期待着2022年公司收入的增长，这将减少我们参与稀释融资的需要。
"I believe we have made great progress in establishing a sturdy foundation, from financial and organizational, to product development, to sales and marketing. We are clear that there remains much to do to further strengthen our foundation. To that end, we were able to retire stock last year and will continue to evaluate what is best for our shareholders and our brands in unison," added Gonzalez.
冈萨雷斯补充说：“我相信，我们在建立坚实的基础方面已经取得了很大进展，从财务和组织，到产品开发，再到销售和营销。我们很清楚，要进一步加强我们的基础，还有很多工作要做。为此，我们去年能够停用股票，并将继续一致地评估什么对我们的股东和我们的品牌最好。”
The company is working on updates to marketing deliverables, including communication to our valued investors and anticipates announcing these efforts early in Q2. Additionally, the Company is working to secure additional clients and the launching of market driven scientific research designed to support the specific value propositions that Boon products provide.
该公司正在更新营销交付成果，包括与我们重要的投资者进行沟通，并预计在第二季度初宣布这些努力。此外，该公司正在努力争取更多的客户，并启动以市场为导向的科学研究，旨在支持Boon产品提供的特定价值主张。
Gonzalez explained the importance of completing Boon's expanded co-manufacturing facility as integral to future revenue growth. "With our expanded footprint we are pursuing larger distribution opportunities for our core brands and have the production capacity to create new product offerings. We now have the ability and capacity to build additional revenue streams for the business and we are finally in the market ready position that we have worked so diligently to place ourselves," said Gonzalez.
冈萨雷斯解释了完成Boon扩大的联合制造设施作为未来收入增长不可或缺的重要性。冈萨雷斯说：“随着我们足迹的扩大，我们正在为我们的核心品牌寻求更大的分销机会，并有能力创造新的产品供应。我们现在有能力和能力为业务建立更多的收入来源，我们终于处于市场准备的地位，我们如此勤奋地工作来定位自己。”
Boon Industries, Inc. (OTC: BNOW) is an innovative bioscience company delivering solutions that benefit people and the planet. At the core of Boon's product offering is DiOx+™ and BioDox™, a chlorine dioxide disinfectant sterilizer. Chlorine dioxide has been approved by OSHA, FDA, EPA, and DOT. DiOx+ kills harmful pathogens without dangerous toxic exposure to the user or the environment. The proprietary chemical formulas and processes behind Boon's products make it ideal for sterilization of mission critical, high value medical equipment and disinfecting air and surfaces in laboratory and hospital environments. BioDox™ helps prevent agricultural crops from disease. Diox+™ is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers and ecommerce support facilities. The introduction of DiOx+ to the U.S. market follows 12 years of chlorine dioxide usage in global markets driven by Boon's CEO Justin Gonzalez. DiOx+ delivers on Boon's promise to provide the most effective, affordable solutions without sacrificing health and safety. DiOx+ is produced at Boon's manufacturing facility and corporate headquarters in Grass Valley, California
Boon Industries，Inc.(场外交易代码：BNOW)是一家创新的生物科学公司，提供造福人类和地球的解决方案。Boon提供的产品的核心是DIOX+™和BIODOX™，这是一种二氧化氯消毒剂消毒器。二氧化氯已获得OSHA、FDA、EPA和DOT的批准。DIOX+杀灭有害病原体，不会对使用者或环境产生危险的有毒物质。Boon产品背后的专利化学配方和工艺使其成为关键任务、高价值医疗设备以及实验室和医院环境中的空气和表面消毒的理想选择。BIODOX™有助于防止农作物患病。DIOX+™用于水处理厂，有助于降低仓储、配送中心和电子商务支持设施的运营成本。在将Diox+引入美国市场之前，在Boon首席执行官贾斯汀·冈萨雷斯的推动下，二氧化氯在全球市场上使用了12年。Diox+兑现了Boon的承诺，在不牺牲健康和安全的情况下提供最有效、最实惠的解决方案。Diox+是在Boon位于加利福尼亚州草谷的制造工厂和公司总部生产的
Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as "believes," "anticipates", "expects", "estimates", "may", "could", "would", "will", or "plan". Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management's expectations. Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law
前瞻性声明的避风港：本新闻稿包含非历史事实的前瞻性陈述。前瞻性陈述包括描述公司未来计划、目标或目标的估计和陈述，包括公司或管理层预期将出现的情况或结果的表述。前瞻性陈述可以用“相信”、“预期”、“预期”、“估计”、“可能”、“可能”、“将”、“将”或“计划”等术语来识别。由于前瞻性陈述以假设为基础，涉及未来的事件和情况，因此它们本身就具有内在的风险和不确定性。虽然这些陈述是基于公司目前掌握的信息，但公司不能保证实际结果将符合管理层的期望。前瞻性信息涉及的风险、不确定性和其他因素可能会导致实际事件、结果、业绩、前景和机会与此类前瞻性信息明示或暗示的内容大不相同。可能导致实际结果与这些前瞻性信息大不相同的因素包括但不限于总体经济和金融市场状况的变化。尽管本公司认为在准备本新闻稿中的前瞻性信息时使用的假设和因素是合理的，但不应过度依赖这些信息，因为这些信息仅适用于本新闻稿发布之日，并且不能保证此类事件将在披露的时间框架内发生或根本不会发生。除法律要求外，公司没有任何更新或修改任何前瞻性信息的意图或义务，无论是由于新信息、未来事件或其他原因
Please note that from time to time the Company may post new information at its website boonindustries.com, or via its current social media accounts below:
请注意，公司可能会不时在其网站上发布新的信息Boonindustries.com，或通过其目前的社交媒体账户如下：
The Company's most current Investor Presentation is available at the following link:
Company Contact
Boon Industries, Inc.
admin@boonindustries.com
公司联系人
福恩实业公司
邮箱：admin@boonIndues.com
Investor Relations & Financial Media
Integrity Media Inc.
team@integritymedia.com
Toll Free: (888) 216-3595
投资者关系与财经媒体
诚信媒体公司。
邮箱：Team@IntegrityMedia.com
免费电话：(888)216-3595
